MetLife Investment Management’s Nikola Corporation Common Stock NKLA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q3
Sell
-1
Closed -$6 2903
2024
Q2
$6 Sell
1
-13,069
-100% -$233K ﹤0.01% 2879
2024
Q1
$408K Buy
13,070
+2,497
+24% +$53.6K ﹤0.01% 1789
2023
Q4
$277K Hold
10,573
﹤0.01% 2050
2023
Q3
$498K Hold
10,573
﹤0.01% 1641
2023
Q2
$438K Buy
10,573
+4,649
+78% +$128K ﹤0.01% 1785
2023
Q1
$215K Hold
5,924
﹤0.01% 2173
2022
Q4
$384K Buy
5,924
+347
+6% +$29K ﹤0.01% 1816
2022
Q3
$589K Buy
5,577
+418
+8% +$70.7K ﹤0.01% 1517
2022
Q2
$737K Buy
5,159
+967
+23% +$198K 0.01% 1393
2022
Q1
$1.35M Buy
4,192
+1,522
+57% +$388K 0.01% 1168
2021
Q4
$791K Hold
2,670
0.01% 1235
2021
Q3
$855K Buy
2,670
+232
+10% +$81.2K 0.01% 1203
2021
Q2
$1.32M Buy
+2,438
New +$1.02M 0.01% 1035

Other funds holding NKLA

MetLife Investment Management's NKLA Position: Q3 2024 in Review

MetLife Investment Management sold out of Nikola Corporation Common Stock (NKLA) in Q3 2024, closing a stake of 1 share — an estimated $6 sold.

MetLife Investment Management first reported a position in NKLA in Q2 2021 and held it in 13 quarters. The position peaked at $1.35M in Q1 2022. 158 funds tracked by Wall St. Rank hold NKLA as of Q3 2024.

  • MetLife Investment Management reported no remaining Nikola Corporation Common Stock position as of Q3 2024 after selling out during the quarter.
  • MetLife Investment Management sold 1 Nikola Corporation Common Stock share in Q3 2024, an estimated $6.
  • MetLife Investment Management first reported a position in Nikola Corporation Common Stock in Q2 2021 and held it in 13 quarters.
  • MetLife Investment Management's Nikola Corporation Common Stock position peaked at $1.35M in Q1 2022.
  • 158 funds tracked by Wall St. Rank held Nikola Corporation Common Stock as of Q3 2024.

Based on MetLife Investment Management's 13F filing for Q3 2024, filed 13 Nov 2024.